A case of antiepiligrin cicatricial pemphigoid successfully treated by plasmapheresis

Dermatology

Volumn 201, Issue 1, 2000, Pages 58-60

  Hashimoto, Yukiko ^a   Suga, Yasushi ^b   Yoshiike, Takashi ^a   Hashimoto, Takashi ^c   Takamori, Kenji ^a  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cicatricial pemphigoid; Epiligrin; Plasmapheresis

Indexed keywords

AUTOANTIBODY; BETAMETHASONE; CYCLOPHOSPHAMIDE; EPILIGRIN; IMMUNOGLOBULIN G ANTIBODY; KALININ; SODIUM CHLORIDE; STEROID;

ADULT; ANTIBODY TITER; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; FEMALE; HUMAN; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE TREATMENT; MUCOUS MEMBRANE PEMPHIGOID; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033813328     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018433     Document Type: Article

References (13)

1. Lazarova Z, Yancey KB: Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/1 salt-split skin: Specificity, sensitivity and practical considerations. J Am Acad Dermatol 1996;35: 398-403.
2. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB: Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509-1518.
3. Lazarova Z, Hsu R, Yee C, Yancey KB: Human anti-laminin 5 autoantibodics induce subepidermal blisters in an experimental human skin graft model. J Invest Dermatol 2000;114: 178-184.
4. Domloge-Hultsch N, Gammon WR, Briggaman R, Gil SG, Carter WG, Yancey KB: Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90:1628-1633.
5. Lazarova Z, Hsu R, Yee C, Yancey KB: Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2). Br J Dermatol 1998;139: 791-797.
6. Agishi T, Kaneko I, Hasuo Y, Hayasaka Y, Sanaka T, Ota K, Amemiya H, Sugino N, Abe M, Ono T, Kawai S, Yamane T: Double filtration plasmapheresis. Trans Am Soc Arlif Intern Organs 1980;26:406-411.
7. Yancey KB: Cicatricial pemphigoid; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Dermatology in General Medicine, ed 5. New York, McGraw-Hill, 1999, vol 1, pp 674-679.
8. Hashimoto T, Murakami H, Senboshi Y, Kanzaki H, Arata J, Yancey KB, Nishikawa T: Antiepiligrin cicatricial pemphigoid: The first case report from Japan. J Am Acad Dermatol 1996;34:940-942.
9. Fujimoto W, Ishida-Yamamoto A, Hsu R, Nagao Y, Iizuka H, Yancey KB: Anti-epiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 1998;139:682-687.
10. Taniuchi K, Takata M, Matsui C, Fushida Y, Uchiyama K, Mori T, Kawana S, Yancey KB, Takehara K: Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Br J Dermatol 1999;140:696-700.
11. Yamada H, Yaguchi H, Takamori K, Ogawa H: Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid. Ther Apheresis 1997;1:178-182.
12. Roujeau JC, Guillaume JC, Morel P, Crickx B, Dalle E, Doutre MS, Guillot B, Godard W, Gorin I, Labeille B: Plasma exchange in bullous pemphigoid. Lancet 1984;ii:486-488.
13. Reimann PM, Maison PD: Plasmapheresis: Technique and complications. Intens Care Med 1990;16:3-10.